Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
<p style="text-align:justify;"> <b>Background:</b> To investigate disease progression the first 12 months after diagnosis in children with type 1 diabetes negative (AAB negative) for pancreatic autoantibodies [islet cell autoantibodies(ICA), glutamic acid decarboxylase a...
Autores principales: | Pörksen, S, Laborie, L, Nielsen, L, Louise Max Andersen, M, Sandal, T, De Wet, H, Schwarcz, E, Aman, J, Swift, P, Kocova, M, Schönle, E, de Beaufort, C, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Mortensen, H, Hansen, L, Njølstad, P |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Ejemplares similares
-
SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group
por: Porksen, S, et al.
Publicado: (2008) -
Monogenic diabetes
por: Kavvoura, FK, et al.
Publicado: (2018) -
Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
por: Davison, L, et al.
Publicado: (2008) -
Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
por: Suhana Bedi, et al.
Publicado: (2022-01-01) -
Editorial: Personalized therapies for monogenic diabetes
por: Maurizio Delvecchio, et al.
Publicado: (2024-09-01)